177 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
9 May 24
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
4:17pm
, starting at 5:00 p.m. Eastern Daylight Time
To access the conference call:
Dial: (800) 715-9871 (toll-free USA and Canada); (646) 307-1963 (international
8-K
EX-99.1
gffs4x68dnn7crs1xvq
13 Mar 24
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
4:16pm
8-K
EX-99.1
dkg1w66r uq
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-99.2
i0to8dt5z01pu cwn
4 Mar 24
Completion of Acquisition or Disposition of Assets
6:22am
8-K
EX-10.1
9i4ka9eyyzyh
5 Feb 24
Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP
8:09am
8-K
EX-99.1
59jh 98gqz
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-2.1
fm5 astv90a1
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
EX-99.1
wute7opot5rfw3q
6 Nov 23
Coherus BioSciences Reports Third Quarter 2023 Financial Results and Business Highlights
4:31pm
8-K/A
EX-99.1
13mgry8 qch1visfw8d
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
42qdwltyxl lhjo
27 Oct 23
Regulation FD Disclosure
4:19pm